UK - The Capital Fund invests in infusion device
A new high accuracy, low cost infusion pump that also has a range of applications in laboratories and the food and chemicals industries, has attracted ТЃ250,000 funding from The Capital Fund.
SECTA uses an innovative rotary mechanism to achieve the continuous flow of liquids pumped through it. The new mechanism is highly accurate, as it is not sensitive to pressure and temperature effects, and it is also significantly more cost-effective than existing peristaltic, syringe and diaphragm pumps on the market. The SECTA pump has one moving disposable part, which can be easily replaced, whereas conventional pumps can have many moving parts, which are highly toleranced and subject to wear, making maintenance difficult and costly.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








